The atherosclerosis-cancer axis: the shared immunotherapeutic potential of CBL inhibition
This editorial refers to ‘The macrophage-derived motor protein KIF13B enhances MERTK-mediated efferocytosis and prevents atherosclerosis in mice’, by Y. Xu et al., https://doi.org/10.1093/eurheartj/ehaf523.Atherosclerosis, a chronic inflammatory disease, remains the leading cause of mortality in the...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
09 September 2025
|
| In: |
European heart journal
Year: 2025, Volume: 46, Issue: 45, Pages: 4985-4987 |
| ISSN: | 1522-9645 |
| DOI: | 10.1093/eurheartj/ehaf624 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/eurheartj/ehaf624
|
| Author Notes: | Kai-Uwe Jarr, Lingfeng Luo, and Nicholas J. Leeper |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1938544250 | ||
| 003 | DE-627 | ||
| 005 | 20251211113448.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 251016s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/eurheartj/ehaf624 |2 doi | |
| 035 | |a (DE-627)1938544250 | ||
| 035 | |a (DE-599)KXP1938544250 | ||
| 035 | |a (OCoLC)1559713151 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Jarr, Kai-Uwe |d 1984- |e VerfasserIn |0 (DE-588)1067200088 |0 (DE-627)818416890 |0 (DE-576)426445066 |4 aut | |
| 245 | 1 | 4 | |a The atherosclerosis-cancer axis |b the shared immunotherapeutic potential of CBL inhibition |c Kai-Uwe Jarr, Lingfeng Luo, and Nicholas J. Leeper |
| 264 | 1 | |c 09 September 2025 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 16.10.2025 | ||
| 520 | |a This editorial refers to ‘The macrophage-derived motor protein KIF13B enhances MERTK-mediated efferocytosis and prevents atherosclerosis in mice’, by Y. Xu et al., https://doi.org/10.1093/eurheartj/ehaf523.Atherosclerosis, a chronic inflammatory disease, remains the leading cause of mortality in the industrialized world, followed closely by cancer.1 Despite its devasting impact, current antiatherosclerotic treatment strategies are largely centred solely around antiplatelet agents and aggressive lipid-lowering therapies. Unfortunately, even with these evidence-based interventions, cardiovascular mortality remains unacceptably high. This underscores a pressing need for fundamentally novel therapeutic strategies to combat this global health burden. A particularly promising avenue lies in harnessing innate immune surveillance, specifically through the cellular processes of phagocytosis and efferocytosis, suggesting that targeted immunotherapy may offer orthogonal, or potentially even synergistic,2 therapeutic solutions.3 | ||
| 700 | 1 | |a Luo, Lingfeng |e VerfasserIn |0 (DE-588)1379113857 |0 (DE-627)1938547233 |4 aut | |
| 700 | 1 | |a Leeper, Nicholas J. |e VerfasserIn |0 (DE-588)1379114381 |0 (DE-627)1938548302 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European heart journal |d Oxford : Oxford University Press, 1980 |g 46(2025), 45, Seite 4985-4987 |h Online-Ressource |w (DE-627)320415813 |w (DE-600)2001908-7 |w (DE-576)103746846 |x 1522-9645 |7 nnas |a The atherosclerosis-cancer axis the shared immunotherapeutic potential of CBL inhibition |
| 773 | 1 | 8 | |g volume:46 |g year:2025 |g number:45 |g pages:4985-4987 |g extent:3 |a The atherosclerosis-cancer axis the shared immunotherapeutic potential of CBL inhibition |
| 856 | 4 | 0 | |u https://doi.org/10.1093/eurheartj/ehaf624 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |7 1 |
| 951 | |a AR | ||
| 992 | |a 20251016 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1067200088 |a Jarr, Kai-Uwe |m 1067200088:Jarr, Kai-Uwe |d 910000 |d 910100 |e 910000PJ1067200088 |e 910100PJ1067200088 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1938544250 |e 4788624311 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 16.10.2025"],"person":[{"family":"Jarr","role":"aut","given":"Kai-Uwe","display":"Jarr, Kai-Uwe"},{"family":"Luo","role":"aut","given":"Lingfeng","display":"Luo, Lingfeng"},{"family":"Leeper","role":"aut","display":"Leeper, Nicholas J.","given":"Nicholas J."}],"recId":"1938544250","language":["eng"],"name":{"displayForm":["Kai-Uwe Jarr, Lingfeng Luo, and Nicholas J. Leeper"]},"origin":[{"dateIssuedDisp":"09 September 2025","dateIssuedKey":"2025"}],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"The atherosclerosis-cancer axis the shared immunotherapeutic potential of CBL inhibitionEuropean heart journal","language":["eng"],"part":{"year":"2025","volume":"46","text":"46(2025), 45, Seite 4985-4987","extent":"3","pages":"4985-4987","issue":"45"},"note":["Gesehen am 12.09.2017"],"pubHistory":["1.1980 -"],"title":[{"title_sort":"European heart journal","title":"European heart journal"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2001908-7"],"issn":["1522-9645"],"eki":["320415813"]},"origin":[{"dateIssuedKey":"1980","publisherPlace":"Oxford ; London [u.a.]","publisher":"Oxford University Press ; Harcourt","dateIssuedDisp":"1980-"}],"recId":"320415813"}],"id":{"eki":["1938544250"],"doi":["10.1093/eurheartj/ehaf624"]},"physDesc":[{"extent":"3 S."}],"title":[{"title":"The atherosclerosis-cancer axis","subtitle":"the shared immunotherapeutic potential of CBL inhibition","title_sort":"atherosclerosis-cancer axis"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a JARRKAIUWEATHEROSCLE0920 | ||